Back to announcement
20241109_SCPI_Pengumuman RUPS_31766165_lamp1.pdf
RUPS notice Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 2
Page 1
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
ANNOUNCEMENT OF THE EXTRAORDINARY GENERAL MEETING
OF SHAREHOLDERS
It is hereby announced to the Shareholders of PT Organon Pharma Indonesia Tbk (the "Company"),
domiciled at Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Setiabudi, Jakarta
Selatan, DKI Jakarta, that the Company will hold an Extraordinary General Meeting of Shareholders (“EGMS”)
(hereinafter referred to as the "Meeting") in Jakarta on Monday, 16 December 2024.
In accordance with the provisions of Article 10 paragraph 5 of the Company's Articles of Association and
Financial Services Authority Regulation Number 15/POJK.04/2020 concerning Plans and Implementation of
General Meeting of Shareholders of Public Companies ("POJK No. 15"), the invitation to the Meeting will be
made on 24 November 2024 through the website of the Indonesia Stock Exchange, and the Company's
website.
Those entitled to attend/represent the Meeting are the Company's Shareholders whose names are registered
in the Company's Shareholders Register on 22 November 2024, 16.00 Western Indonesian Time (WIB) or
the Company's shareholders in the securities sub account PT Kustodian Sentral Efek Indonesia (KSEI) at the
close of trading day on the Indonesia Stock Exchange (IDX) on 22 November 2024, 16.00 Western
Indonesian Time (WIB).
One or more Shareholders who (together) represent 1/20 (one twentieth) or more of the total number of
shares of the Company with valid voting rights that have been issued by the Company may propose a meeting
agenda. The proposal of the Company's Shareholders will be included in the agenda of the Meeting if it meets
the provisions of Article 10 paragraph 3 of the Company's Articles of Association and Article 16 of POJK No.
15, namely:
a. The proposal is submitted in writing and received by the Board of Directors of the Company no later
than 17 November 2024, at 14.00 Western Indonesian Time (WIB);
b. Accompanied by the reasons and materials for the proposed agenda items of the Meeting;
c. The proposal is an agenda item that requires Meeting Resolutions and does not conflict with statutory
regulations; and
d. The proposal was made in good faith, taking into account the interests of the Company and directly
related to the Company's business.
The announcement of this Meeting can also be accessed on the website of the Indonesian Central Securities
Depository (www.ksei.co.id), the website of the Indonesia Stock Exchange (www.idx.co.id), and the
Company's website (https://www.organon.com/indonesia/).
Jakarta, 9 November 2024
PT ORGANON PHARMA INDONESIA Tbk
Board of Directors
Page 2
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
PENGUMUMAN
RAPAT UMUM PEMEGANG SAHAM LUAR BIASA
Dengan ini diumumkan kepada para Pemegang Saham PT Organon Pharma Indonesia Tbk (“Perseroan”),
berkedudukan di Sinarmas MSIG Tower, Lantai 37 Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Setiabudi,
Jakarta Selatan, DKI Jakarta, bahwa Perseroan akan menyelenggarakan Pemegang Saham Perseroan
untuk menghadiri Rapat Umum Pemegang Saham Luar Biasa (“RUPSLB”) (selanjutnya disebut “Rapat”) di
Jakarta pada hari Senin, 16 Desember 2024.
Sesuai dengan ketentuan dalam Pasal 10 ayat 5 Anggaran Dasar Perseroan serta memperhatikan Peraturan
Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana dan Penyelenggaraan Rapat Umum
Pemegang Saham Perusahaan Terbuka (“POJK No. 15”), Pemanggilan Rapat akan dilakukan pada 24
November 2024 melalui situs web Bursa Efek Indonesia, dan situs web Perseroan.
Yang berhak menghadiri/mewakili dalam Rapat adalah Pemegang Saham Perseroan yang namanya tercatat
dalam Daftar Pemegang Saham Perseroan pada tanggal 22 November 2024 pukul 16.00 Waktu Indonesia
Barat (WIB) atau pemilik saham Perseroan pada sub rekening efek PT Kustodian Sentral Efek Indonesia
(KSEI) pada penutupan perdagangan saham di Bursa Efek Indonesia (BEI) tanggal 22 November 2024 pukul
16.00 WIB.
Seorang Pemegang Saham atau lebih yang (bersama-sama) mewakili 1/20 (satu per dua puluh) atau lebih
dari jumlah seluruh saham Perseroan dengan hak suara yang sah yang telah dikeluarkan oleh Perseroan
dapat mengajukan usulan mata acara Rapat. Usulan Pemegang Saham Perseroan tersebut akan dimasukan
dalam mata acara Rapat jika memenuhi ketentuan Pasal 10 ayat 21 Anggaran Dasar Perseroan dan Pasal
16 POJK No. 15, yakni:
a. Usul tersebut diajukan tertulis dan diterima Direksi Perseroan paling lambat tanggal 17 November
2024 pukul 14.00 Waktu Indonesia Barat;
b. Disertai alasan dan bahan usulan mata acara Rapat;
c. Usul tersebut merupakan mata acara yang membutuhkan Keputusan Rapat serta tidak
bertentangan dengan peraturan perundang-undangan; dan
d. Usul tersebut dilakukan dengan itikad baik, mempertimbangkan kepentingan Perseroan dan
berhubungan langsung dengan usaha Perseroan.
Pengumuman Rapat ini juga dapat diakses pada situs web PT Kustodian Sentral Efek Indonesia
(www.ksei.co.id), situs web Bursa Efek Indonesia (www.idx.co.id), dan situs web Perseroan
(https://www.organon.com/indonesia/).
Jakarta, 9 November 2024
PT ORGANON PHARMA INDONESIA Tbk
Direksi
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1
unresolved
org
Indonesia Stock Exchange
p.1 ×3
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1 ×5
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.